MarketCap
Facebook
X
TelegramAnnual report 2025
added 05-02-2025
Streamline Health Solutions Total Assets 2011-2026 | STRM
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Streamline Health Solutions
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.6 M | 41.7 M | 61.5 M | 61.8 M | 26 M | 31.7 M | 31.7 M | 37.1 M | 41.6 M | 50.1 M | 55.8 M | 65.6 M | 55.3 M | 25.1 M | 16 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 65.6 M | 16 M | 42.4 M |
Quarterly Total Assets Streamline Health Solutions
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36 M | 39 M | 41.7 M | 41.7 M | 41.1 M | 53.3 M | 56.5 M | 61.5 M | 62.2 M | 57 M | 60 M | 26 M | 62.4 M | 37.8 M | 40 M | 31.7 M | 25.3 M | 28.3 M | 28.5 M | 31.7 M | 31.3 M | 31.6 M | 32 M | 37.1 M | 33.1 M | 36.1 M | 37.3 M | 41.6 M | 34.5 M | 37.5 M | 38.1 M | 49.9 M | 40.1 M | 44.5 M | 45.5 M | 55.8 M | 49.6 M | 54.1 M | 52 M | 65.6 M | 56.7 M | 62.1 M | 61.6 M | 55.3 M | 52.7 M | 53.8 M | 51.4 M | 25.1 M | 52.9 M | 25.1 M | 24.6 M | 16 M | 14.7 M | 14.9 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 65.6 M | 14.7 M | 42.2 M |
Total Assets of other stocks in the Health information services industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
7.43 B | - | - | $ 27.9 B |  USA |
 |
Computer Programs and Systems
CPSI
|
434 M | - | 4.4 % | $ 133 M | USA |
 |
Change Healthcare
CHNG
|
9.93 B | - | - | $ 9.03 B | USA |
 |
Accolade
ACCD
|
476 M | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
167 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
1.33 B | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
1.97 B | - | - | $ 6.37 B | USA |
 |
Covetrus
CVET
|
3.41 B | - | - | $ 2.94 B | USA |
 |
Evolent Health
EVH
|
1.82 B | $ 2.74 | 3.6 % | $ 257 M | USA |
 |
HealthStream
HSTM
|
511 M | $ 20.35 | 2.36 % | $ 618 M | USA |
 |
Progyny
PGNY
|
607 M | $ 20.83 | -0.71 % | $ 1.79 B | USA |
 |
Health Catalyst
HCAT
|
859 M | $ 1.83 | -0.82 % | $ 110 M | USA |
 |
iCAD
ICAD
|
37.5 M | - | - | $ 102 M | USA |
 |
Akerna Corp.
KERN
|
7.63 M | - | - | $ 161 M | USA |
 |
10x Genomics
TXG
|
965 M | $ 18.95 | 8.22 % | $ 2.22 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
2.43 B | - | -10.39 % | $ 886 M | USA |
 |
HealthEquity
HQY
|
3.16 B | $ 73.1 | -0.15 % | $ 6.25 B | USA |
 |
American Well Corporation
AMWL
|
324 M | $ 5.58 | 28.87 % | $ 89.5 M | USA |
 |
MTBC
MTBC
|
71.6 M | - | -0.58 % | $ 51.7 M | USA |
 |
So-Young International
SY
|
2.74 B | $ 3.28 | -5.07 % | $ 260 M |  China |
 |
GoodRx Holdings
GDRX
|
1.39 B | $ 2.19 | 0.69 % | $ 845 M | USA |
 |
Omnicell
OMCL
|
2.12 B | $ 36.63 | 1.24 % | $ 1.69 B | USA |
 |
OptimizeRx Corporation
OPRX
|
183 M | $ 8.86 | 7.92 % | $ 152 M | USA |
 |
1Life Healthcare
ONEM
|
2.63 B | - | - | $ 3.37 B | USA |
 |
Premier
PINC
|
3.1 B | - | - | $ 2.33 B | USA |
 |
Phreesia
PHR
|
370 M | $ 12.28 | 3.54 % | $ 670 M | USA |
 |
Zhongchao
ZCMD
|
25.9 M | $ 0.21 | -5.71 % | $ 1.09 M | China |
 |
R1 RCM
RCM
|
1.45 B | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
160 M | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
644 M | - | - | $ 1.6 B | USA |
 |
Schrödinger
SDGR
|
823 M | $ 11.43 | 1.06 % | $ 831 M | USA |
 |
Signify Health
SGFY
|
1.74 B | - | -0.02 % | $ 7.21 B | USA |
 |
Teladoc Health
TDOC
|
3.52 B | $ 4.77 | 6.71 % | $ 814 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
384 M | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
5.91 B | $ 174.22 | 1.3 % | $ 28 B | USA |
 |
SCWorx Corp.
WORX
|
6.35 M | $ 0.27 | 7.01 % | $ 394 K | USA |